The expansion provides for focused use of the current Brotas industrial fermentation capacity to supply Amyris’s current partners and collaborators based on projected demand for Biofene® (Amyris-branded farnesene) serving the polymers, nutraceuticals and solvents markets through 2020.
Expected demand will require new farnesene manufacturing capacity beyond the company’s current capacity at its Brotas plant. Amyris is in active discussions with current collaborators and partners to provide financing for the project, with construction expected to start in the second half of 2016.
